In Vitro Fertilization Market Expected To Hit US$ 40.6 Billion By 2032

Introduction

The Global In Vitro Fertilization Market size is expected to be worth around USD 40.6 Billion by 2032, from USD 21.0 Billion in 2023, growing at a CAGR of 7.8% during the forecast period from 2023 to 2032. In 2022, North America led the market, achieving over 43% share with a revenue of US$ 8.3 Billion.

The global In Vitro Fertilization (IVF) market, a pivotal component of Assisted Reproductive Technology (ART), is experiencing substantial growth, driven by various technological and strategic advancements. Annually, IVF contributes to around half a million births worldwide, reflecting its increasing adoption.

Several factors are propelling the expansion of the IVF market. Advanced genetic screening technologies play a crucial role by improving IVF success rates and preventing genetic disorders from being passed on during the procedure. Additionally, broader insurance coverage is making IVF treatments more affordable and accessible.

Technological innovations in the field, such as enhanced culture media and superior imaging systems, have significantly increased the success rates of IVF. Further, the integration of artificial intelligence (AI) in embryo selection processes marks a notable trend, optimizing treatment efficiency and outcomes. Non-invasive techniques are also gaining traction, improving patient experience and safety.

Fertility tourism is another growth driver, with countries like the Czech Republic offering cost-effective treatment options that attract international patients. In North America, lifestyle-related infertility issues are stimulating demand for IVF solutions.

The market benefits from significant research and development activities by leading companies, which introduce advancements such as sophisticated imaging systems and sperm separation technologies. These innovations address male infertility and enhance overall patient care.

Overall, the IVF market is expanding across both instrumental and technological aspects, with fertility and surgical centers leading the market due to their specialized services and comprehensive care. AI applications in IVF are setting new standards for success rates, exemplified by companies like Oma Fertility that offer AI-driven fertility treatments.

Key Takeaways

• In 2022, the global in vitro fertilization market was valued at $19.5 billion, with a projected CAGR of 7.8% from 2023 to 2032.
• IVF with ICSI represented 43% of the market due to its effectiveness, especially for male infertility, making it a preferred choice.
• The equipment segment is projected to hold 59% of the market share, driven by more IVF procedures and advanced technology.
• Fresh non-donor IVF cycles are expected to grow rapidly due to their high success rates, especially with unfrozen eggs.
• Fertility clinics led the market, accounting for over 79% of revenue, due to increased demand and accessibility.
• Delayed pregnancies and associated infertility risks have globally increased IVF adoption, linking infertility to delayed parenthood.
• The transfer of multiple embryos in IVF presents risks like premature birth and low birth weight, affecting market growth.
• Developing countries like India and Brazil offer affordable IVF treatments, creating significant opportunities in medical tourism.

In Vitro Fertilization Statistics

• IVF Treatment Cycles and Success Rates:
  • Annual IVF Cycles: There was an 11% increase in IVF cycles, rising from 69,000 in 2019 to 77,000 in 2022.
  • Donor Insemination Cycles: These cycles have remained stable, with around 6,000 cycles in 2022.
  • Success Rates: Fresh embryo transfers reported a 31% pregnancy success rate in 2022. The highest IVF success rates, at 42%, were among patients aged 18-34.
  • Age Factors: The average age of first-time IVF patients was over 35 years in 2022, while donor insemination patients averaged 33.6 years. In England and Wales, the average age for first births was 29.2 years in 2022.
• Funding and Accessibility:
  • NHS Funding: NHS-funded IVF cycles decreased to 27% in 2022 from 40% in 2012. Funding for IVF dropped by 17% in England and 16% in Wales from 2019 to 2022. Scotland experienced a 7% reduction in NHS-funded IVF cycles over the same period.
• General IVF Data:
  • Procedure Duration: An IVF cycle typically spans 3 to 6 weeks.
  • ART Dominance: In 2021, IVF constituted over 99% of all assisted reproductive technology (ART) procedures, producing 86,146 infants, or 2.3% of all U.S. births.
  • Infertility Statistics: About 9% of married U.S. women aged 15-49 and approximately 9% of U.S. men aged 15-44 experienced infertility issues. Around 12.5% of U.S. women aged 15-49 have utilized infertility services in their lifetime.
• IVF Contributions to Births:
  • Live Birth Rates: IVF accounts for 1.6% of all live births in the United States and 4.5% in Europe. The highest success rates for natural cycle IVF reach up to 44% for male factor infertility.
• IVF Procedures and Protocols:
  • Embryo Transfer: The American Society for Reproductive Medicine (ASRM) guidelines permit up to 2 blastocysts for women under 37 years, and up to 3 for women aged 38 to 42.
  • OHSS Incidence: The incidence of severe Ovarian Hyperstimulation Syndrome (OHSS) ranges from 0.2% to 1% of all stimulation cycles.
• Multiple Births and Miscarriage Rates:
  • Multiple Births: From 1980 to 2015, 19% of all twins and 25% of all triplets resulted from IVF. Higher success rates are observed in younger individuals; significantly lower after age 40.
  • Miscarriage Rates: Miscarriage rates are similar to those of natural conception—about 15% for those in their 20s and over 50% for those in their 40s.
• Costs and Post-Procedure Care:
  • IVF Costs: The average cost of an IVF cycle ranges from $12,000 to $17,000.
  • Post-Procedure Care: Progesterone is administered for 8 to 10 weeks post-embryo transfer to support the uterine lining and embryo growth. A pregnancy test is conducted about 12 to 14 days after embryo transfer to confirm pregnancy.

Emerging Trends

• Integration of Artificial Intelligence (AI): Artificial intelligence is revolutionizing In Vitro Fertilization (IVF) by improving the prediction of pregnancy outcomes. AI technologies analyze embryo viability, aiding in the selection of the most promising embryos for implantation. This use of AI not only aims to elevate IVF success rates but also helps reduce miscarriage rates. Sophisticated algorithms that evaluate embryo development are setting new standards in reproductive technologies, enhancing efficiency and broadening accessibility for those seeking fertility treatments.
• Advancements in Stem Cell Research: Stem cell technology is leading the advancement of fertility treatments, with research focused on regenerating damaged ovarian tissue and enhancing egg quality. This innovative approach could significantly transform fertility options, especially for those affected by age or health-related egg-quality decline. The potential to improve egg quality and ovarian function through stem cells could dramatically increase the success rates of IVF treatments, offering hope to many aspiring parents.
• Enhanced Embryo Selection Techniques: The selection of embryos during IVF has been greatly refined by technologies like time-lapse imaging and microfluidics. These methods provide continuous, precise monitoring of embryo development, allowing fertility specialists to choose the best candidates for successful pregnancy based on comprehensive, real-time data. Improved embryo selection processes not only heighten the precision but also boost the overall success rates of IVF cycles.
• Cryopreservation Techniques: The practice of cryopreservation, particularly through vitrification, is advancing and becoming more prevalent. This method freezes eggs, sperm, and embryos at ultra-low temperatures to stop biological activity, preserving their viability for future use. Vitrification allows individuals and couples to postpone pregnancy for various reasons without compromising genetic material quality, offering greater flexibility in family planning.
• Non-Invasive Genetic Testing: Non-invasive genetic testing methods are transforming preimplantation genetic diagnostics by reducing risks to embryos while still providing critical genetic information. This advancement is likely to boost genetic testing’s integration into IVF, ensuring embryo health and increasing the likelihood of successful implantation. As these methods evolve, they are expected to standardize, providing potential parents with reassurance and significantly lowering the incidence of genetic disorders.
• Automation and Robotics in IVF: The adoption of robotics and automated systems in IVF clinics is enhancing the precision and consistency of various procedures, from sperm selection to embryo transfer. Automation minimizes human error and could make treatments more standardized and cost-effective. With robotic accuracy, fertility clinics are improving treatment outcomes, making IVF more accessible and reliable as part of a broader trend towards efficient and dependable reproductive healthcare solutions.

Use Cases

• Overcoming Infertility: In vitro fertilization (IVF) is a vital solution for various infertility issues, including age-related fertility decline, polycystic ovarian syndrome (PCOS), and male factor infertility characterized by sperm mobility or count problems. As a leading form of assisted reproductive technology, IVF facilitates the fertilization process outside the body, significantly enhancing conception chances for those facing infertility challenges, thereby offering hope and a viable route to pregnancy.
• Prevention of Genetic Disorders: IVF plays a crucial role in preventing genetic disorders through advanced genetic screening techniques like preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS). These techniques allow for the examination of embryos for genetic abnormalities before implantation. For couples at risk of transmitting genetic conditions, IVF is essential in selecting healthy embryos, substantially increasing the prospects of birthing a healthy child.
• Fertility Preservation: IVF is instrumental in fertility preservation, particularly for individuals about to undergo medical treatments like chemotherapy or radiation, which might impair fertility. By preserving eggs or sperm prior to treatment, IVF ensures that patients have the potential to conceive biological children in the future. This capability is especially significant for cancer patients within their reproductive years, planning for family life post-treatment.
• Enabling Diverse Family Building: IVF expands family-building possibilities for single individuals and same-sex couples, offering them the chance for biological parenthood where natural conception is unfeasible. For same-sex couples, IVF can involve one partner providing the sperm or egg, with the addition of a donor, facilitating a biological link with the child. This adaptability of IVF has profoundly impacted family dynamics, reflecting and accommodating modern social and personal lifestyle choices.
• Assistance with Advanced Maternal Age: As more people opt to start families later in life, IVF becomes a crucial aid for older women experiencing a natural decline in fertility due to advanced maternal age. IVF addresses the challenges posed by reduced egg quantity and quality in women over 35, utilizing specialized techniques to maximize fertilization and implantation success rates. This application of IVF supports the shifting societal views on the timing of parenthood and career progression, providing older women with a realistic opportunity to conceive.

Conclusion

The global In Vitro Fertilization (IVF) market is poised for robust growth, fueled by technological advancements and increased accessibility. Innovations such as artificial intelligence in embryo selection and non-invasive genetic testing are enhancing success rates and safety, making IVF a more viable option for many.

With the rising prevalence of infertility related to lifestyle and age, coupled with growing interest in fertility tourism, the market is set to expand significantly. Furthermore, the development of new technologies in genetic screening and embryo preservation continues to broaden IVF’s appeal, promising improved outcomes and accessibility for prospective parents worldwide.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF